Literature DB >> 8826549

Pain assessment of subcutaneous injections.

J T Jørgensen1, J Rømsing, M Rasmussen, J Møller-Sonnergaard, L Vang, L Musaeus.   

Abstract

OBJECTIVE: To compare injection pain after subcutaneous administration of four different solution volumes.
DESIGN: Double-blind, randomized, prospective, multiple crossover study.
SETTING: Steno Diabetes Center, Gentofte, Denmark. PARTICIPANTS: Eighteen healthy volunteers, 9 women and 9 men, aged 21-30 years.
METHODS: The subjects were injected with four different volumes (0.2, 0.5, 1.0, 1.5 mL) of NaCl 0.9%. The study was performed on 2 days with a 1-week washout period between the study days. On each study day the subjects received four injections in each thigh. To evaluate the validity of our pain assessing model the subjects received eight injections of 0.5% mL on one of the study days. Pain assessment was done immediately after each injection using both a 10-cm visual analog scale (VAS) and a six-item verbal rating scale (VRS).
RESULTS: A significant difference in pain score on both the VAS (p < 0.05) and the VRS (p < 0.01) was seen between the four injection volumes. The pain was significantly increased with volumes of 1.0 and 1.5 mL. No significant difference in injection pain could be detected between 0.2 and 0.5 mL and between 1.0 and 1.5 mL. No significant period or carryover effect could be detected in the study. A significant correlation between the pain score on the VAS and the pain score on the VRS was found (r = 0.79, p < 0.0001).
CONCLUSIONS: The pain of a subcutaneous injection is related to injection volume in the thigh. The results show that increasing the volume from 0.5 to 1.0 mL increases the pain significantly. The findings from this study should be considered when injection preparations for subcutaneous administration are formulated. The volume should generally be less than 1.0 mL if injected into the thigh.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8826549     DOI: 10.1177/106002809603000703

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  16 in total

1.  Impact of a modified needle tip geometry on penetration force as well as acceptability, preference, and perceived pain in subjects with diabetes.

Authors:  Laurence Hirsch; Michael Gibney; Julie Berube; John Manocchio
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

2.  Acceptability of Liquid Human Growth Hormone (hGH) [Norditropin Simple Xx®] in Adults and Children with GH Deficiency and Children with Chronic Renal Disease.

Authors:  M L Drent; S Jakobsdottir; J A E van Wijk; W Oostdijk; J M Wit
Journal:  Clin Drug Investig       Date:  2002-09       Impact factor: 2.859

3.  Drug use problems with self-injected low-molecular-weight heparins in primary care.

Authors:  Seraina Mengiardi; Dimitrios A Tsakiris; Markus L Lampert; Kurt E Hersberger
Journal:  Eur J Clin Pharmacol       Date:  2010-11-24       Impact factor: 2.953

4.  A comparison of the tolerability of two dilution volumes (0.5 mL and 1.0 mL) of a purified chick embryo cell rabies vaccine administered intramuscularly to healthy adult volunteers: A randomized, intraindividual, assessor-blind study.

Authors:  Renuka Kulkarni; Urmila Thatte; Vaishali Shinde; Shalaka Dharadhar; Olga Popova; Hoshang Vakil
Journal:  Curr Ther Res Clin Exp       Date:  2004-01

5.  Golimumab: A novel human anti-TNF-alpha monoclonal antibody for the treatment of rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis.

Authors:  Jonathan Kay; Mahboob U Rahman
Journal:  Core Evid       Date:  2010-06-15

6.  Tolerability and safety of novel half milliliter formulation of glatiramer acetate for subcutaneous injection: an open-label, multicenter, randomized comparative study.

Authors:  G Anderson; D Meyer; C E Herrman; C Sheppard; R Murray; E J Fox; J Mathena; J Conner; P O Buck
Journal:  J Neurol       Date:  2010-10-16       Impact factor: 4.849

7.  Tralokinumab pharmacokinetics and tolerability when administered by different subcutaneous injection methods and rates
.

Authors:  Meena Jain; Diane Doughty; Corbin Clawson; Xiaobai Li; Nicholas White; Balaji Agoram; René van der Merwe
Journal:  Int J Clin Pharmacol Ther       Date:  2017-07       Impact factor: 1.366

8.  Indian Injection Technique Study: Injecting Complications, Education, and the Health Care Professional.

Authors:  Sanjay Kalra; Ambrish Mithal; Rakesh Sahay; Mathew John; A G Unnikrishnan; Banshi Saboo; Sujoy Ghosh; Debmalya Sanyal; Laurence J Hirsch; Vandita Gupta; Kenneth W Strauss
Journal:  Diabetes Ther       Date:  2017-03-13       Impact factor: 2.945

9.  Clinical Evaluation of an Investigational 5 mL Wearable Injector in Healthy Human Subjects.

Authors:  Wendy D Woodley; Wen Yue; Didier R Morel; Audrey Lainesse; Ronald J Pettis; Natasha G Bolick
Journal:  Clin Transl Sci       Date:  2021-03-25       Impact factor: 4.689

10.  Evaluation of the impact of viscosity, injection volume, and injection flow rate on subcutaneous injection tolerance.

Authors:  Cecile Berteau; Orchidée Filipe-Santos; Tao Wang; Humberto E Rojas; Corinne Granger; Florence Schwarzenbach
Journal:  Med Devices (Auckl)       Date:  2015-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.